September 22, 2021 Chemicals, Reagents & Kits Licensing, IP, and Legal

Zymo Research Receives CE IVD Mark for Its EZ DNA Methylation-Lightning Kit

PROVEN BISULFITE TECHNOLOGY IDEAL FOR CLINICAL APPLICATIONS IRVINE, Calif., (September 22, 2021) — Today Zymo Research announced its EZ DNA Methylation-Lightning Kit has received the CE IVD Mark allowing the technology to be distributed within the European Union (EU) common market. Chemical treatment of DNA with bisulfite is the prerequisite for many methylation-based diagnostic assays. Clinical diagnostic and... Read more

September 22, 2021 Licensing, IP, and Legal Microscopy PAI Top-10 Product Launch

Roche launches three respiratory test panels on cobas 6800/8800 Systems in CE markets to help identify multiple pathogens with overlapping symptoms in patients

Acute respiratory infections are one of the leading causes of death and disability globally, presenting substantial health challenges especially for infants, the elderly and the immunocompromised.1-3 Three new molecular diagnostic test panels for influenza and other common respiratory illnesses can be run together or alone using one patient sample. Flexible syndromic testing tailored to patient... Read more

September 15, 2021 Acad, Gov/Utilities Chromatography Clinical Research/Diagn. Lab Top-10 Licensing, IP, and Legal Life Science Tools PAI Top-10

FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda's Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations

FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda’s Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations Oncomine Dx Target Test now approved as CDx for five targeted NSCLC therapies in the U.S. CARLSBAD, Calif., Sept. 15, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher... Read more

September 13, 2021 Clinical Research/Diagn. Licensing, IP, and Legal Liq. Handling & Robotics

Quanterix Receives Label Expansion On Emergency Use Authorization For COVID Antigen Test

Simoa SARS-CoV-2 N Protein Antigen Test is first antigen test validated to detect all Variants of Concern currently designated by CDC, including Delta variant, and first authorized for use in saliva samples EUA label expansion demonstrates additional evidence showing potential for Simoa technology across range of clinical tests, including less-invasive testing BILLERICA, Mass., September 13,... Read more

September 6, 2021 Environ, Ag./Food & Bev Licensing, IP, and Legal Liq. Handling & Robotics Microscopy PAI Top-10

The Intricate Network of Immune Cells Revealed by Multiplex Tissue Microscopy

When our immune systems identify invaders – such as parasites, bacteria or viruses – it can spark inflammation, which brings fluid and immune cells to the area of infection. While this can be very effective in battling infection, it also has collateral damage on nearby healthy tissues. In our daily lives, just by eating or... Read more

September 2, 2021 Acad, Gov/Utilities Lab Top-10 Licensing, IP, and Legal PR/Corporate

Thermo Fisher Scientific Awarded $192.5 Million U.S. Government Contract to Expand Domestic Pipette Tip Manufacturing

Thermo Fisher Scientific Awarded $192.5 Million U.S. Government Contract to Expand Domestic Pipette Tip Manufacturing New capacity will help U.S. customers meet current and future demand surges for vital laboratory plastics WALTHAM, Mass., Sept. 2, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a $192.5 million contract... Read more

August 30, 2021 Lab Top-10 Licensing, IP, and Legal

Bruker Corporation to Participate in the 2021 Wells Fargo Virtual Healthcare Conference

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2021 Wells Fargo Virtual Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer, and Falko Busse, President of the Bruker BioSpin Group, will participate in an analyst moderated question and answer session on behalf of the Company on Friday,... Read more

August 27, 2021 Licensing, IP, and Legal

Roche provides update on Tecentriq US indication for PD-L1-positive, metastatic triple-negative breast cancer

Basel, 27 August 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the company has made the decision to voluntarily withdraw the US accelerated approval for Tecentriq® (atezolizumab) in combination with chemotherapy (Abraxane®, albumin-bound paclitaxel; nab-paclitaxel) for the treatment of adults with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC) whose tumours... Read more

August 24, 2021 Environ, Ag./Food & Bev Lab Top-10 Licensing, IP, and Legal PR/Corporate

Danaher Announces Human Resources And Accounting Leadership Transition Plans

WASHINGTON, Aug. 24, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced that, effective April 1, 2022, Georgeann F. Couchara will succeed Angela S. Lalor as Senior Vice President, Human Resources. At that time, Ms. Lalor will move to a part time, advisory role until her retirement in the first quarter of 2023. Ms. Couchara, currently Vice President,... Read more